Welcome to LookChem.com Sign In|Join Free
  • or
Benzyl 2,3-dihydroxypropanoate is a chemical compound that features a benzyl group attached to a 2,3-dihydroxypropanoate group. It is recognized for its distinctive sweet, floral, and fruity aroma, which contributes to its widespread use in the fragrance industry.

73573-57-6

Post Buying Request

73573-57-6 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

73573-57-6 Usage

Uses

Used in Fragrance Industry:
Benzyl 2,3-dihydroxypropanoate serves as a key fragrance ingredient due to its appealing scent profile. It is utilized for imparting a sweet, floral, and fruity aroma to a variety of consumer products, enhancing their sensory appeal and consumer experience.
Used in Cosmetics and Personal Care Products:
In the cosmetics and personal care sector, benzyl 2,3-dihydroxypropanoate is employed as a fragrance component. Its incorporation into these products allows for the creation of pleasant and attractive scents, which can improve the overall user experience and product acceptance.
Used in Perfumes:
Benzyl 2,3-dihydroxypropanoate is also a popular choice in the formulation of perfumes. Its unique aroma adds depth and complexity to perfume blends, contributing to the creation of distinctive and memorable fragrances.

Check Digit Verification of cas no

The CAS Registry Mumber 73573-57-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,3,5,7 and 3 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 73573-57:
(7*7)+(6*3)+(5*5)+(4*7)+(3*3)+(2*5)+(1*7)=146
146 % 10 = 6
So 73573-57-6 is a valid CAS Registry Number.

73573-57-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name benzyl 2,3-dihydroxypropanoate

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:73573-57-6 SDS

73573-57-6Relevant academic research and scientific papers

Dihydroxylation of Olefins with Potassium Permanganate Catalyzed by Imidazolium Salt

Khan, Imran,Luo, Zhi-Bin,Valeru, Anil,Xu, Yin,Liu, Bin,Sangepu, Bhavanarushi,Xie, Ji-Min

, p. 1815 - 1819 (2018/02/19)

The development of an efficient and cost-effective cis -dihydroxylation reaction of acrylate derivatives was achieved. The reaction proceeded in acetone with an imidazolium salt as catalyst to furnish the dihydroxylation of olefins at 0-5 °C using KMnO 4 as the oxidant. This efficient and non-aqueous protocol was highly suitable for the large-scale preparation of cis -dihydroxylated compounds from the corresponding acrylate derivatives in high yields without overoxidation.

Intermolecular Carboamination of Unactivated Alkenes

Zhang, Yu,Liu, Haidong,Tang, Luning,Tang, Hai-Jun,Wang, Lu,Zhu, Chuan,Feng, Chao

supporting information, p. 10695 - 10699 (2018/09/06)

Herein, we report the first example of group transfer radical addition of O-vinylhydroxylamine derivatives onto unactivated alkenes. By utilizing O-vinylhydroxylamine derivatives as both the N- and C-donors, this reaction enables intermolecular carboamination of unactivated alkenes in an atom economical fashion. As the process is initiated through N-radical addition followed by C-transfer, linear carboamination products are afforded. This differs from canonical radical carbofunctionalization of olefins, which typically favors branched product owing to initiation by C-radical addition.

INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE

-

Page/Page column 265; 266, (2017/11/10)

Described herein are compounds that inhibit ALK2 and its mutants, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions.

SKIN TREATMENTS CONTAINING CARBOXYLIC ACID-SUBSTITUTED IDEBENONE DERIVATIVES AND METHODS OF PREPARATION AND USE THEREOF

-

Page/Page column 8-9, (2010/04/30)

The present invention relates to novel carboxylic acid-substituted idebenone derivatives, skin treatment compositions containing these carboxylic acid-substituted idebenone derivatives, methods of treating skin changes by topical application of these carb

MASKED CARBOXYLATE NEOPENTYL SULFONYL ESTER CYCLIZATION RELEASE PRODRUGS OF ACAMPROSATE, COMPOSITIONS THEREOF, AND METHODS OF USE

-

Page/Page column 50, (2009/04/24)

Masked carboxylate neopentyl sulfonyl ester prodrugs of acamprosate, pharmaceutical compositions comprising such prodrugs, and methods of using such prodrugs and compositions thereof for treating diseases are disclosed. In particular, acamprosate prodrugs

Derivatives and analogs

-

, (2008/06/13)

Preparation of phosphonoformic acid analogues containing one, two, three, or more sulfur atoms are described, with specific examples. Such compounds, not excluding cognates, derivatives, and homologues thereof, are proposed to be used directly, or as prodrugs, in treating viral infections, including but not limited to HIV, herpesviruses including HSV, EBV, VZV, CMV, HSV-6 and HSV-8 (Kaposi's sarcoma); HPV; rhinoviruses; and hepatitis-linked viruses. They are also proposed to be used in treating neoplasms, and for diagnosis and therapy of diseases of bone metabolism. The compounds of the present invention are also designed as to create novel biologically active compounds or prodrugs.

Synthesis and antiviral activity of a series of pyrophosphate analogs

-

, (2008/06/13)

Preparations of pyrophosphate analogues, including phosphonoformic acid, bisphosphonic acid, and phosphonoacetic acid derivatives, exhibiting antiviral activity. Such compounds, are used directly, or as prodrugs, in compositions and methods for treating viral infections, including but not limited to HIV, herpesviruses including HSV, EBV, VZV, CMV, HHV-6 and HHV-8 (Kaposi's sarcoma); HPV; rhinoviruses; and hepatitis-linked viruses. Compounds of the present invention for use as antiviral agents or their intermediates include sulfur-containing, polyhydroxy, and lipophilic derivatives of phosphonoformic acid.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 73573-57-6